Health Care·Health Care Equipment·$17.7B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.94 | N/A | +3.47% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $1.94 | N/A | +3.47% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management expressed satisfaction with the EPS results, highlighting a commitment to long-term growth. However, they did not provide specific revenue guidance.
We are pleased with our EPS performance this quarter.
While we did not provide revenue guidance, we remain focused on our long-term strategies.
Zimmer Biomet's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the stock reacted negatively, declining by 0.92%. This could be due to the lack of revenue guidance, leaving investors uncertain about future performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
BANCO BILBAO VIZCAYA ADR
Apr 29, 2024